site banner

Eli Lilly releases data for a new weight-loss drug to tackle obesity : Shots - Health News : NPR

npr.org

This drug is a true gamechanger

In the SURMOUNT-1 study, people who took the highest dose of tirzepatide, most of whom had a BMI of about 30 or higher but did not have diabetes, lost about 21% of their body weight during the 72 week study. As researchers point out, for people who have bariatric surgery, typical weight loss is about 25% to 30% of their weight, one or two years after the surgery. In the tirzepatide study, 36% of people taking the highest dose lost 25% or more of their body weight.

this is comparable to bariatric surgery

11
Jump in the discussion.

No email address required.

Excellent. Since these drugs work by suppressing appetite the government should fund the creation of a related GLP-1 agonist that it owns the patent on then distribute them for free to everyone in the country on demand (cheap since gov owns patent). The people taking the drugs will be significantly better off, the savings on food stamps etc. will be enough to make up the few billion development costs in a few years and as a side effect there will be fewer ugly people on the street. Win win for everyone.

Put it in the toothpaste. (Yes, it's a reference.)